Last reviewed · How we verify

NCT05099419

Repetitive Transcranial Magnetic Stimulation in Women With Overactive Bladder With Urgency Incontinence

Status unknown EARLY_PHASE1 Last updated 17 November 2021
What this trial tests

EARLY_PHASE1 trial testing Repetitive Transcranial Magnetic Stimulation in Overactive Bladder in 10 participants. Status unknown.

Timeline
28 October 2021
Primary endpoint
30 April 2022
30 June 2022

Quick facts

Lead sponsorUniversity of Southern California
PhaseEARLY_PHASE1
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment10
Start date28 October 2021
Primary completion30 April 2022
Estimated completion30 June 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Southern California

Who can join

18 and older, female only, with Overactive Bladder or Urge Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Overactive bladder (OAB) affects an estimated 16-30% of women in the US and urgency urinary incontinence (UUI) affects 7-11% of women with OAB. It is known that repetitive transcranial magnetic stimulation (rTMS) over the supplementary motor area (SMA) can modulate the pelvic floor muscle activity with potential benefits for various urologic conditions. The goal of this study is to assess feasibility of rTMS as a treatment option for OAB with UUI by determining which rTMS frequency is most effective in targeting sensory components of OAB, namely urinary urgency, and also in targeting the brain network known to be involved in OAB.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Repetitive Transcranial Magnetic Stimulation

Trials testing the same drug.

Other recruiting trials for Overactive Bladder

Currently open trials in the same condition.

Other University of Southern California trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05099419.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing